Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Annarita Fanizzi"'
Autor:
Annarita Fanizzi, Maria Colomba Comes, Samantha Bove, Elisa Cavalera, Paola de Franco, Alessia Di Rito, Angelo Errico, Marco Lioce, Francesca Pati, Maurizio Portaluri, Concetta Saponaro, Giovanni Scognamillo, Ippolito Troiano, Michele Troiano, Francesco Alfredo Zito, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Several studies have emphasised how positive and negative human papillomavirus (HPV+ and HPV−, respectively) oropharyngeal squamous cell carcinoma (OPSCC) has distinct molecular profiles, tumor characteristics, and disease outcomes. Differ
Externí odkaz:
https://doaj.org/article/3a58af39bb7947f98b520802b8a424b4
Autor:
Annarita Fanizzi, Francesca Arezzo, Gennaro Cormio, Maria Colomba Comes, Gerardo Cazzato, Luca Boldrini, Samantha Bove, Michele Bollino, Anila Kardhashi, Erica Silvestris, Pietro Quarto, Michele Mongelli, Emanuele Naglieri, Rahel Signorile, Vera Loizzi, Raffaella Massafra
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Accurate characterization of newly diagnosed a solid adnexal lesion is a key step in defining the most appropriate therapeutic approach. Despite guidance from the International Ovarian Tumor Analyzes Panel, the evaluation of these
Externí odkaz:
https://doaj.org/article/44af02c27261412ca746736e2556be09
Autor:
Annarita Fanizzi, Agnese Latorre, Domenica Antonia Bavaro, Samantha Bove, Maria Colomba Comes, Erika Francesca Di Benedetto, Federico Fadda, Daniele La Forgia, Francesco Giotta, Gennaro Palmiotti, Nicole Petruzzellis, Lucia Rinaldi, Alessandro Rizzo, Vito Lorusso, Raffaella Massafra
Publikováno v:
Cancer Medicine, Vol 12, Iss 22, Pp 20663-20669 (2023)
Abstract Background About 15%–20% of breast cancer (BC) cases is classified as Human Epidermal growth factor Receptor type 2 (HER2) positive. The Neoadjuvant chemotherapy (NAC) was initially introduced for locally advanced and inflammatory BC patie
Externí odkaz:
https://doaj.org/article/09ceace074754b4d818a5d03705312d5
Autor:
Annarita Fanizzi, Federico Fadda, Maria Colomba Comes, Samantha Bove, Annamaria Catino, Erika Di Benedetto, Angelo Milella, Michele Montrone, Annalisa Nardone, Clara Soranno, Alessandro Rizzo, Deniz Can Guven, Domenico Galetta, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Non-Small cell lung cancer (NSCLC) is one of the most dangerous cancers, with 85% of all new lung cancer diagnoses and a 30–55% of recurrence rate after surgery. Thus, an accurate prediction of recurrence risk in NSCLC patients during diag
Externí odkaz:
https://doaj.org/article/355cb18e617c4a91bae039c14b60162d
Autor:
Maria Chiara Carriero, Antonio Leo, Alessia Lezzi, Roberto Lupo, Luana Conte, Annarita Fanizzi, Raffaella Massafra, Elsa Vitale, Antonio Carriero
Publikováno v:
Diseases, Vol 12, Iss 7, p 141 (2024)
Background: The suffering associated with a cancer diagnosis can find different channels to express itself: sleep disorders, psychiatric disorders, sexuality. These are not always analyzed by health professionals, but they have an impact on the patie
Externí odkaz:
https://doaj.org/article/4b6f424bc84f4cb99b77dbfcc071f96e
Autor:
Annarita Fanizzi, Elisabetta Graps, Domenica Antonia Bavaro, Marco Farella, Samantha Bove, Francesco Campobasso, Maria Colomba Comes, Cristian Cristofaro, Daniele La Forgia, Martina Milella, Serena Iacovelli, Rossella Villani, Rahel Signorile, Alessio De Bartolo, Vito Lorusso, Raffaella Massafra
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background A timely diagnosis is essential for improving breast cancer patients’ survival and designing targeted therapeutic plans. For this purpose, the screening timing, as well as the related waiting lists, are decisive. Nonetheless, ev
Externí odkaz:
https://doaj.org/article/b59197b746434e709dda2aa41325ece7
Autor:
Annarita Fanizzi, Domenico Pomarico, Alessandro Rizzo, Samantha Bove, Maria Colomba Comes, Vittorio Didonna, Francesco Giotta, Daniele La Forgia, Agnese Latorre, Maria Irene Pastena, Nicole Petruzzellis, Lucia Rinaldi, Pasquale Tamborra, Alfredo Zito, Vito Lorusso, Raffaella Massafra
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract For endocrine-positive Her2 negative breast cancer patients at an early stage, the benefit of adding chemotherapy to adjuvant endocrine therapy is not still confirmed. Several genomic tests are available on the market but are very expensive.
Externí odkaz:
https://doaj.org/article/b56ee393ea0943caa915c1041b0d325d
Autor:
Alessandro Rizzo, Angela Dalia Ricci, Annarita Fanizzi, Raffaella Massafra, Raffaele De Luca, Giovanni Brandi
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 749-757 (2023)
Recent years have observed the emergence of novel therapeutic opportunities for advanced hepatocellular carcinoma (HCC), such as combination therapies including immune checkpoint inhibitors. We performed a meta-analysis with the aim to compare median
Externí odkaz:
https://doaj.org/article/cc45d79da76944e9b521e0743b3f13be
Autor:
Gianluca Gatta, Francesco Somma, Celestino Sardu, Marco De Chiara, Raffaella Massafra, Annarita Fanizzi, Daniele La Forgia, Vincenzo Cuccurullo, Francesco Iovino, Alfredo Clemente, Raffaele Marfella, Graziella Di Grezia
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 12, p 1683 (2023)
Purpose: The purpose of this meta-analysis is to investigate the effectiveness of supplementing screening mammography with three-dimensional automated breast ultrasonography (3D ABUS) in improving breast cancer detection rates in asymptomatic women w
Externí odkaz:
https://doaj.org/article/699dfc6da991458889b1dc63d73ea5a9
Autor:
Maria Colomba Comes, Francesca Arezzo, Gennaro Cormio, Samantha Bove, Angela Calabrese, Annarita Fanizzi, Anila Kardhashi, Daniele La Forgia, Francesco Legge, Isabella Romagno, Vera Loizzi, Raffaella Massafra
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIt has been estimated that 19,880 new cases of ovarian cancer had been diagnosed in 2022. Most epithelial ovarian cancer are sporadic, while in 15%–25% of cases, there is evidence of a familial or inherited component. Approximately 20%
Externí odkaz:
https://doaj.org/article/e4ee8236009f4e84b00a2a07a5bfbd04